Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Circulation

• Publication date

  2001-11-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HC4601.099402PMID 11714658
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans.

  2000cited by this paper
• Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation

  2000cited by this paper
• Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease

  2000cited by this paper
• Two distinct forms of MAPKAP kinase-2 in adult cardiac ventricular myocytes.

  2000cited by this paper
• Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.

  2000cited by this paper
• Basic mechanisms of atrial fibrillation--very new insights into very old ideas.

  2000cited by this paper
• Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

  2000cited by this paper
• Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.

  1999cited by this paper
• Effects of beta-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol-induced heart failure in the rat.

  1999cited by this paper
• Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice.

  1999cited by this paper
• Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

  1999cited by this paper
• Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts.

  1998cited by this paper
• Cellular mechanisms of cardiac hypertrophy

  1998cited by this paper
• Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension.

  1998cited by this paper
• "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium.

  1998cited by this paper
• Cell Type–Specific Angiotensin II–Evoked Signal Transduction Pathways

  1998cited by this paper
• Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat.

  1997cited by this paper
• Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat.

  1997cited by this paper
• Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

  1997cited by this paper
• Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors.

  1997cited by this paper
• Stress-activated protein kinases in cardiovascular disease.

  1996cited by this paper
• Mechanical stretch activates the stress‐activated protein kinase in cardiac myocytes

  1996cited by this paper
• Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction.

  1995cited by this paper
• Newer developments in the management of atrial fibrillation.

  1995cited by this paper
• Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.

  1994cited by this paper
• Antiarrhythmic effect of converting enzyme inhibitors in congestive heart failure.

  1994cited by this paper
• Antiarrhytmic effect of converting enzyme inhibitors in congestive heart failure

  1994cited by this paper
• Myocardial fibrosis: functional significance and regulatory factors.

  1993cited by this paper
• Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.

  1993cited by this paper
• Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.

  1993cited by this paper
• Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.

  1993cited by this paper
• Angiotensin II Receptor Blockade After Myocardial Infarction in Rats: Effects on Hemodynamics, Myocardial DNA Synthesis, and Interstitial Collagen Content

  1992cited by this paper
• DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril.

  1991cited by this paper
• Remodeling of the rat right and left ventricles in experimental hypertension.

  1990cited by this paper
• Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease.

  1984cited by this paper
• Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis.

  1982cited by this paper

• P-wave peak time: An emerging electrocardiographic marker of atrial stress and ischemic burden-review.

  2026cites this paper
• Targeting HSP90 suppresses STAT1/CCL8-driven inflammation and mitigates mitochondrial dysfunction to attenuate hypertension-induced atrial fibrillation.

  2026cites this paper
• Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment

  2025cites this paper
• Association of Estimated Glomerular Filtration Rate (eGFR) and High-Sensitivity C-Reactive Protein (Hs-CRP) with the Risk of New-Onset Atrial Fibrillation in Patients with Diabetes

  2025cites this paper
• Computational modelling of cardiac fibroblast signalling reveals a key role for Ca2+ in driving atrial fibrillation-associated fibrosis.

  2025cites this paper
• Arrhythmia-induced cardiomyopathy: focus on atrial fibrillation

  2025cites this paper
• Exploring Anti-Inflammatory Treatment as Upstream Therapy in the Management of Atrial Fibrillation

  2025cites this paper
• A Case of Success: Guidelines-Based Treatment to Control Atrial Fibrillation-Induced Cardiomyopathy—Atrioventricular Node Ablation and Cardiac Resynchronization Therapy to the Rescue

  2025cites this paper
• Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction: New Insights and Unresolved Questions.

  2025cites this paper
• Electrocardiographic P-wave indices and onset of atrial fibrillation and histological fibrosis in a general Japanese population: a prospective cohort analysis of the Hisayama Study

  2025cites this paper
• Interactions between atrial fibrosis and inflammation in atrial fibrillation

  2025cites this paper
• Atrial cardiomyopathy revisited—evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)

  2024cites this paper
• Atrial Fibrillation and Underlying Structural and Electrophysiological Heterogeneity

  2024cites this paper
• PATHOPHYSIOLOGICAL AND STRUCTURAL PECULIARITIES OF CARDIAC FIBROSIS DEVELOPMENT IN ATRIAL FIBRILLATION

  2024cites this paper
• Chronic angiotensin converting enzyme inhibition attenuates frailty and protects against atrial fibrillation in aging mice.

  2024cites this paper
• Activated factor X stimulates atrial endothelial cells and tissues to promote remodeling responses through AT1R/NADPH oxidases/SGLT1/2.

  2024cites this paper
• Translation of pathophysiological mechanisms of atrial fibrosis into new diagnostic and therapeutic approaches

  2024cites this paper
• Updates on the Renin–Angiotensin–Aldosterone System and the Cardiovascular Continuum

  2024cites this paper
• Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week.

  2024cites this paper
• Oxidative stress and atrial fibrillation.

  2024cites this paper
• Atrial Myopathy.

  2024cites this paper
• Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets

  2024cites this paper
• microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation

  2023cites this paper
• Sinus node dysfunction and atrial fibrillation-Relationships, clinical phenotypes, new mechanisms, and treatment approaches.

  2023cites this paper
• Diminished α7 nicotinic acetylcholine receptor (α7nAChR) rescues amyloid-β induced atrial remodeling by oxi-CaMKII/MAPK/AP-1 axis-mediated mitochondrial oxidative stress

  2023cites this paper
• Atrial arrhythmias and heart failure: A “modern view” of an old paradox

  2023cites this paper
• CIB2 Is a Novel Endogenous Repressor of Atrial Remodeling

  2023cites this paper
• Alterations in cytoskeletal and Ca2+ cycling regulators in atria lacking the obscurin Ig58/59 module

  2023cites this paper
• The ratio of cytochrome c oxidase subunit 4 isoform 4I1 and 4I2 mRNA is changed in permanent atrial fibrillation

  2023cites this paper
• Tipping the scales of understanding: An engineering approach to design and implement whole-body cardiac electrophysiology experimental models

  2023cites this paper
• The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives

  2023cites this paper
• Network Pharmacology and Molecular Docking Analysis on Mechanisms of Scutellariae Radix in the Treatment of Cerebral Ischemia-reperfusion Injury.

  2023cites this paper
• Management of Chronic Congestive Heart Failure Caused by Myxomatous Mitral Valve Disease in Dogs: A Narrative Review from 1970 to 2020

  2022cites this paper
• Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation

  2022cites this paper
• Artificial intelligence analysis of the impact of fibrosis in arrhythmogenesis and drug response

  2022cites this paper
• Mechanism and prevention of atrial remodeling and their related genes in cardiovascular disorders.

  2022cites this paper
• Development and validation of a nomogram for predicting atrial fibrillation in patients with acute heart failure admitted to the ICU: a retrospective cohort study

  2022cites this paper
• The Atrium in Atrial Fibrillation – A Clinical Review on How to Manage Atrial Fibrotic Substrates

  2022cites this paper
• Atrial fibrillation and stroke

  2022cites this paper
• The Effect of Angiotensin II Receptor Blockers in Patients with Hypertrophic Cardiomyopathy: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials

  2022cites this paper
• Low-Voltage Area at the Anterior Wall of the Left Atrium Is Associated With Thromboembolism in Atrial Fibrillation Patients With a Low CHA2DS2-VA Score

  2022cites this paper
• A novel therapeutic strategy for alleviating atrial remodeling by targeting exosomal miRNAs in atrial fibrillation.

  2022cites this paper
• Atrial fibrillation in the presence and absence of heart failure enhances expression of genes involved in cardiomyocyte structure, conduction properties, fibrosis, inflammation, and endothelial dysfunction.

  2022cites this paper
• Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation

  2022cites this paper
• Identification of circRNA-miRNA-mRNA Regulatory Network and Autophagy Interaction Network in Atrial Fibrillation Based on Bioinformatics Analysis

  2021cites this paper
• Atrial Fibrillation and Heart Failure: Epidemiology, Pathophysiology, Prognosis, and Management.

  2021cites this paper
• Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation

  2021cites this paper
• Electrophysiological Consequences of Cardiac Fibrosis

  2021cites this paper
• A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation

  2021cites this paper
• Atrial fibrosis and substrate based characterization in atrial fibrillation: Time to move forwards

  2021cites this paper
• Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management

  2021cites this paper
• The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19

  2021cites this paper
• Sacubitril/Valsartan Decreases Atrial Fibrillation Susceptibility by Inhibiting Angiotensin II-Induced Atrial Fibrosis Through p-Smad2/3, p-JNK, and p-p38 Signaling Pathways

  2021cites this paper
• In-hospital acute kidney injury and atrial fibrillation: incidence, risk factors, and outcome

  2021cites this paper
• Small-Molecule Integrated Stress Response Inhibitor Reduces Susceptibility to Postinfarct Atrial Fibrillation in Rats via the Inhibition of Integrated Stress Responses

  2021cites this paper
• THE ROLE OF PHOSPHORYLATION IN ATRIAL FIBRILLATION: A FOCUS ON MASS SPECTROMETRY APPROACHES.

  2021cites this paper
• Left Atrial Myopathy in Atrial Fibrillation and Heart Failure: Clinical Implications, Mechanisms, and Therapeutic Targets

  2021cites this paper
• Atrial fibrillation in patients with heart failure with preserved ejection fraction.

  2020cites this paper
• Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF Stroke Prophylaxis

  2020cites this paper
• Atrial fibrosis as a dominant factor for the development of atrial fibrillation: facts and gaps.

  2020cites this paper
• Bioactive peptides attenuate cardiac hypertrophy and fibrosis in spontaneously hypertensive rat hearts.

  2020cites this paper
• Atrial fibrosis underlying atrial fibrillation (Review).

  2020cites this paper
• A Molecular Genetic Perspective on Atrial Fibrillation

  2020cites this paper
• Épidémiologie et mécanismes de la fibrillation atriale

  2020cites this paper
• Prognostic significance of present atrial fibrillation on a single office electrocardiogram in patients with atrial fibrillation

  2020cites this paper
• A meta-analysis of ECG abnormalities (arrhythmias) in different types of heart failure

  2020cites this paper
• Two-week continuous monitoring of heart rhythm in chronic kidney disease

  2020cites this paper
• p38 MAPK Pathway in the Heart: New Insights in Health and Disease

  2020cites this paper
• Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure

  2020cites this paper
• Upstream Therapy for Atrial Fibrillation Prevention: The Role of Sacubitril/Valsartan

  2020cites this paper
• Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy

  2020cites this paper
• Atrial fibrillation in the elderly: A risk factor beyond stroke.

  2020cites this paper
• Central sleep apnea and atrial fibrillation: A review on pathophysiological mechanisms and therapeutic implications

  2020cites this paper
• [Review Articles].

  2020cites this paper
• Antiarrhythmic Properties of Non-Antiarrhythmic Drugs in Atrial Fibrillation: Upstream Therapy

  2020cites this paper
• Anti-arrhythmic Effects of Non-anti-arrhythmic Drugs or Therapies

  2020cites this paper
• Atrial Fibrillation Management in Heart Failure: Interrupting the Vicious Cycle

  2020cites this paper
• Large animals as models of atrial fibrillation.

  2020cites this paper
• Atrial Myopathy

  2019cites this paper
• Novel Personalised Determinants of Atrial Substrate in Atrial Fibrillation

  2019cites this paper
• Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?

  2019cites this paper
• Atrial Fibrillation in Heart Failure—Diagnostic, Therapeutic, and Prognostic Relevance

  2019cites this paper
• Biomarkers of Atrial Fibrillation in Metabolic Syndrome.

  2019cites this paper
• Body composition changes assessment by bioelectrical impedance vectorial analysis in right heart failure and left heart failure.

  2019cites this paper
• TGFβ1 and HGF regulate CTGF expression in human atrial fibroblasts and are involved in atrial remodelling in patients with rheumatic heart disease

  2019cites this paper
• Cardiac Therapeutics in Horses.

  2019cites this paper
• Atrial Fibrillation Ablation Should Be First-Line Therapy in Heart Failure Patients: CON.

  2019cites this paper
• AGE–RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment

  2019cites this paper
• DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.

  2018cites this paper
• Role of Stress Kinase JNK in Binge Alcohol-Evoked Atrial Arrhythmia

  2018cites this paper
• Role of Monocytes in Heart Failure and Atrial Fibrillation

  2018cites this paper
• Shengmai San-derived herbal prevents the development of a vulnerable substrate for atrial fibrillation in a rat model of ischemic heart failure.

  2018cites this paper
• Stress Signaling JNK2 Crosstalk With CaMKII Underlies Enhanced Atrial Arrhythmogenesis

  2018cites this paper
• Muscarinic type-1 receptors regulate I K,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation

  2018cites this paper
• Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.

  2018cites this paper
• Atrial fibrillation ablation in heart failure

  2018cites this paper
• Renin–angiotensin–aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy

  2018cites this paper
• Targeting the Substrate in Ablation of Persistent Atrial Fibrillation: Recent Lessons and Future Directions

  2018cites this paper
• Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure

  2018cites this paper
• Hypertension and Atrial Fibrillation: Doubts and Certainties From Basic and Clinical Studies

  2018cites this paper